Bladder Cancer,Genitourinary Cancer MIBC: TMT With PD-1 Inhibitor and Hypo-Fractionated Radiation Jan 22, 2024
Bladder Cancer,Genitourinary Cancer EG-70: Promising Safety & Efficacy in High-Risk Bladder Cancer Jan 09, 2024
Bladder Cancer,Genitourinary Cancer Subcutaneous Fat Area as Parastomal Hernia Risk: PUBMIC Trial Data Jan 08, 2024
Bladder Cancer,Genitourinary Cancer Erdafitinib in BCG-Resistant HR NMIBC With FGFR Mutations Dec 20, 2023
Bladder Cancer,Genitourinary Cancer Real-World Use of Avelumab Maintenance in Advanced UC Patients Dec 14, 2023
Bladder Cancer,Genitourinary Cancer Erdafitinib vs. Pembrolizumab in Advanced UC With FGFR Alterations Dec 14, 2023
